Impeto Medical is a privately owned medical device company formed in June 2005 with its corporate headquarters in Paris, France. Impeto Medical manufactures and markets devices designed for non-invasive assessment of eccrine sweat gland activity.
Impeto Medical has developed a technology that assesses sudomotor function.
Based on this technology, Impeto Medical has developped EZSCAN, a device that allows the detection of diabetes risk.
Impeto Medical has recently launched SUDOSCAN+, a device for the diagnosis and follow-up of diabetes complications.
Lien RSS